[Abstract] [Full Text PDF] (in Japanese / 2996KB) [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 89(10): 1594-1602, 1988


Original article

PHARMACODYNAMIC STUDY OF THE IN VITRO CLONOGENIC ASSAY
-WITH REFERENCE TO THE DOSE LEVELS-

Department of Surgery, School of Medicine, Keio University, Tokyo, Japan

Yoh Isobe

To determine the optimal condition of the clonogenic assay, the antitumor activities of 5-fluorouracil (5-FU) in vitro and in vivo were investigated from a pharmacodynamic viewpoint using 8 human carcinoma xenografts.
The clonogenic assay was performed by the continuous exposure method, and the antitumor effects were evaluated by the colony survival rates (T/Cs). The in vivo experimental chemotherapy was also performed by the nude mouse system, and the results were evaluated by the T/C ratios of the tumor weights. For pharmacokinetic analyses, the area under the concentration curves (AUCs) of 5-FU in vitro and in vivo were computed.
The T/Cs of 5-FU were highly correlated to the AUCs both in vitro and in vivo. By using these AUC-T/C correlations, the concentration of 5-FU in the clonogenic assay to predict the T/C of the maximum tolerated dose in mouse was calculated to be 3μg/ml mathematically. This concentration was then verified by the clonogenic assay, where T/Cs in vitro could successfully correspond to the T/Cs in vivo. (The predictable rate was 87.5%)
From these results, this pharmacodynamic comparison between in vitro and in vivo chemosensitivities was thought to be a promising method for determining the conditions of the clonogenic assay.


<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.